drugset / Trial / NCT04818736
COVID-19 Vaccine For Indirect Protection
Phase 4
Withdrawn
McMaster University
University of Alberta · collabUniversity of Manitoba · collabUniversity of Saskatchewan · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The primary objective of this study is to test whether vaccinating adults ≥18 years in Hutterite colonies with mRNA-1273 (Moderna COVID-19) vaccine as compared to control (usual care) can prevent RT-PCR confirmed COVID-19 in non-vaccinated Hutterite members.
Timeline
- Start
- 2021-04-15
- Primary completion
- 2021-09
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elasomeran | Messenger RNA (mRNA) | 0.5 ml | — |
Indications
No indication recorded.